Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors

NCT04305795 is registered in ClinicalTrials.gov with Rakuten Medical, Inc. as lead sponsor.

NCT NCT04305795
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04305795 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Study Using ASP-1929 Photoimmunotherapy in Combination With Anti-PD1 Therapy in EGFR Expressing Advanced Solid Tumors
Lead sponsor
Rakuten Medical, Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
December 21, 2020
Completion date
June 30, 2027
Enrollment
23 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

locally advanced cutaneous squamous cell carcinoma, metastatic cutaneous squamous cell carcinoma, metastatic head-and-neck squamous-cell carcinoma, recurrent head and neck squamous cell carcinoma